Searched for
VYMADA
Novartis heart drug price may fall by 60% on generic rollouts"At least 30-40 generic brands are expected to hit the market next in a couple of weeks," said Hari Natarajan, managing director, Pronto Co...19 Jan, 2023, 12.41 AM IST- Natco Plea: Delhi high court sets aside Novartis patentNatco filed writ petition citing procedural irregularities and violation of principles of natural justice by the Assistant Controller of Pa...13 Jan, 2023, 12.21 AM IST
- HC reserves order on Natco's plea over patent for Novartis drugNatco has argued before Justice C Hari Shankar against the grant of patent by IPO to the pharmaceutical composition comprising combination ...11 Jan, 2023, 11.53 PM IST
- Delhi HC restrains generic pharma firms from making, selling patent drug of NovartisThe plea said the plaintiff through a press release of January 28, 2019 issued by the defendant came to know about its act in launching a p...02 Nov, 2021, 01.39 PM IST
- Natco dares Novartis with new heart drugAccording to data from AIOCD PharmaTrac, an agency that closely tracks pharmaceutical sales, Vymada had sales of Rs 68.3 crore for December...30 Jan, 2019, 10.35 AM IST
- Stocks in the news: DHFL, ICICI Bank, Bajaj Auto, NTPC, BoB, Axis and YES BankHere are a few stocks, which may buzz the most in today's trade.30 Jan, 2019, 08.42 AM IST
- There’s an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, NovartisOur chief focus for future investments will be: One on increasing our R&D footprint here over time. Second is data and digital.21 Aug, 2018, 07.11 AM IST
Load More
